Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Huntsman Ronald Kirk
Chief Executive Officer at Vivos Therapeutics. Filing since 11 Dec 2020.
CIK 0001835498
Company
Date
Role
Action
Shares
Amount
Of holding
VVOS
Vivos Therapeutics, Inc.
20 Jun 2023
Chief Executive Officer
Bought
14,000
$7.42K
19.3%
VVOS
Vivos Therapeutics, Inc.
16 Jun 2023
Chief Executive Officer
Bought
15,000
$8.05K
26.1%
VVOS
Vivos Therapeutics, Inc.
15 Jun 2023
Chief Executive Officer
Bought
21
$10.50
0.0%
VVOS
Vivos Therapeutics, Inc.
14 Jun 2023
Chief Executive Officer
Bought
10,000
$4.90K
21.1%
VVOS
Vivos Therapeutics, Inc.
23 Dec 2022
Chief Executive Officer
Bought
20,000
$10.00K
72.7%
VVOS
Vivos Therapeutics, Inc.
1 Jun 2022
Chief Executive Officer
Bought
4,000
$7.32K
17.0%
VVOS
Vivos Therapeutics, Inc.
31 May 2022
Chief Executive Officer
Bought
8,000
$16.24K
51.6%
VVOS
Vivos Therapeutics, Inc.
21 Sep 2021
Chief Executive Officer
Bought
5,000
$21.55K
47.6%
VVOS
Vivos Therapeutics, Inc.
17 Aug 2021
Chief Executive Officer
Bought
5,000
$15.00K
90.9%
VVOS
Vivos Therapeutics, Inc.
25 May 2021
Chief Executive Officer
Bought
4,000
$21.52K
267%
VVOS
Vivos Therapeutics, Inc.
23 Dec 2020
Chief Executive Officer
Bought
1,000
$7.27K
200%
VVOS
Vivos Therapeutics, Inc.
11 Dec 2020
Chief Executive Officer
Bought
500
$4.25K
opened
12 decisions on file.
